Paudel et al., 2018
Laboratory studies have suggested that GLP-1 receptor activation may modulate inflammatory pathways, though the clinical relevance of these findings remains uncertain
Here's why: when you're losing weight on a GLP-1, your body doesn't just lose fat
Consumption Shifts Among GLP-1 Households Early trends indicate that GLP-1 households are pulling back on food and alcohol purchases more significantly than households without GLP-1 users, particularly those with individuals using GLP-1 drugs for weight loss
Therefore, drugs with a potent antihyperglycemic effect, independent of the glomerular filtration rate, with a low risk of hypoglycemia, that reduce weight in overweight/obese patients and that provide cardiovascular and renal protection, such as GLP-1 receptor agonists, are needed
L., Dicker, D., Mingrone, G., Pedersen, S